Centessa Pharmaceuticals Plc (CNTA)
39.76
+0.06
(+0.15%)
USD |
NASDAQ |
Jun 09, 16:00
39.76
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals SG&A Expense (Quarterly) : 19.85M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 607.30M |
| Roivant Sciences Ltd. | 158.25M |
| Eli Lilly & Co. | 2.934B |
| Aptorum Group Ltd. | 0.2117M |
| Bicycle Therapeutics Plc | 17.44M |